Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patientsAkihiko Osaki, Tetsuya Toge, Katsumasa Kuroi et al.|The American Journal of Surgery|1992Cited by 72
Myxoma of the breast: Report of a case with unique histological and immunohistochemical appearancesKoji Arihiro, Tetsuya Toge, Nasima Khatun et al.|Acta Pathologica Japonica|1993Cited by 8
Modulation of CD4 Antigen Expression on the Lymphocyte Surface by Immunosuppressive Acidic Protein in Cancer PatientsYoshiyuki Yamaguchi, Tetsuya Toge, Eiji Miyahara et al.|Oncology|2009Cited by 7
The expression and biological activity of IL-2 receptor on a human pancreas cancer cell lineHiroyuki Kawami, Tetsuya Toge, Kazuhiro Yoshida et al.|Biotherapy|1993Cited by 4
A combination therapy with mitomycin c, etoposide, doxifluridine and medroxyprogesterone acetate as second line therapy for advanced breast cancer refractory to combination chemotherapy of cyclophosphamide, doxorubicin and 5 fluorouracilKatsumasa Kuroi, Tetsuya Toge, Hiroyuki Kawami et al.|Breast Cancer|1997Cited by 1